Article Text

Download PDFPDF
Identification of Cervical Cancer Proteins Associated With Treatment With Paclitaxel and Cisplatin in Patients
  1. Huiling Liu, MD*,
  2. Yin Han, PhD,
  3. Ruoran Mi, MD,
  4. Ying Zhang, MD, PhD§,
  5. Gang Su, MA,
  6. Hailin Wang, MA*,
  7. Xin Zhou, MA,
  8. Xiangwen Liu, MA and
  9. Bingdong Zhu, MD
  1. *Department of Obstetrics and Gynecology, Gansu Provincial People's Hospital;
  2. Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu;
  3. Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China; and
  4. §Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
  1. Address correspondence and reprint requests to Bingdong Zhu, MD, or Ying Zhang, MD, PhD, Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, 199 West Danggang Road, Lanzhou, China (730000). E-mail: bdzhu{at}lzu.edu.cn or yzhang{at}jhsph.edu.

Abstract

Objective: Neoadjuvant chemotherapy (NAC) with paclitaxel (T) and cisplatin (P) was commonly used for the treatment of cervical cancer. However, little is known about the antineoplastic mechanism of NAC with TP in patient tissues in situ. In this study, we compared the proteomic profiles of cervical cancer in patients before and after NAC with TP to identify proteins that may shed light on the mechanism of TP action.

Methods: We collected cervical cancer tissues pre- and post-NAC with TP from 6 patients with local advanced cervical cancer and stored them at −80°C. Proteomes of 2 groups of cervical cancer tissues were analyzed by 2-dimensional gel electrophoresis and the differentially expressed proteins were identified by matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry. Some proteins that are differentially expressed were confirmed by Western blot.

Results: There were 13 proteins whose levels were significantly altered after NAC with TP. Compared with pre-NAC, 11 proteins were down-regulated, and 2 proteins were up-regulated in the post-NAC group. The down-regulated proteins were aldolase A, pyruvate kinase, enolase 1, heat shock protein 27 (HSP27), HSP70, actinin α1, lamin B1, eukaryotic translation elongation factor 1γ, annexin 1, epithelial cell marker protein1, keratin II-type. In contrast, apolipoprotein A1 and annexin V were up-regulated. The down-regulation of HSP27, HSP70, enolase 1, and aldolase A was verified by Western blot.

Conclusions: Differentially expressed proteins between cervical cancer tissues pre- and post-NAC with TP were identified by comparative proteomic approach. The NAC therapy with TP down-regulated proteins involved in energy production (glycolytic enzymes) and chaperones but up-regulated proteins involved in apoptosis. These findings shed new light on biomarkers associated with effect of chemotherapy.

  • Cervical carcinoma
  • Proteomics
  • Paclitaxel
  • Cisplatin
  • Neoadjuvant chemotherapy

Statistics from Altmetric.com

Footnotes

  • The authors declare that there are no conflicts of interest.

  • This work was supported by the Changjiang Scholar fund (Y.Z.) and talent supporting fund from the Ministry of Education of China (NCET-07-0403) (B.Z.).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.